Soleus Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-409,000
| Closed | -$26.8M | – | 76 |
|
|
2024
Q4 | $26.8M | Buy |
+409,000
| New | +$26.8M | 1.68% | 18 |
|
|
2022
Q3 | – | Sell |
-169,696
| Closed | -$11.2M | – | 78 |
|
|
2022
Q2 | $11.2M | Buy |
169,696
+57,000
| +51% | +$3.77M | 1.75% | 19 |
|
|
2022
Q1 | $7.48M | Sell |
112,696
-365,900
| -76% | -$24.3M | 0.96% | 34 |
|
|
2021
Q4 | $27.9M | Buy |
478,596
+159,200
| +50% | +$9.27M | 2.79% | 5 |
|
|
2021
Q3 | $19.2M | Buy |
319,396
+69,250
| +28% | +$4.16M | 2.99% | 9 |
|
|
2021
Q2 | $15M | Sell |
250,146
-8,300
| -3% | -$497K | 2.3% | 14 |
|
|
2021
Q1 | $12.9M | Buy |
258,446
+194,162
| +302% | +$9.65M | 2.32% | 8 |
|
|
2020
Q4 | $3.21M | Buy |
64,284
+55,081
| +599% | +$2.75M | 0.42% | 25 |
|
|
2020
Q3 | $504K | Sell |
9,203
-127,011
| -93% | -$6.96M | 0.27% | 55 |
|
|
2020
Q2 | $7.2M | Buy |
+136,214
| New | +$7.2M | 4.11% | 4 |
|